{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:18:40Z","timestamp":1788153520679,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Critically ill patients often experience substantial glycemic fluctuations, which are associated with adverse clinical outcomes. Conventional point-of-care glucose monitoring provides only intermittent measurements and may delay timely therapeutic adjustment. Continuous glucose monitoring (CGM) enables real-time assessment of glucose trends and may improve glycemic management in intensive care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, retrospective, real-world propensity score\u2013matched cohort study included 592 critically ill adults admitted to the intensive care unit. Patients receiving CGM-guided glucose management were matched 1:1 with patients receiving standard point-of-care glucose monitoring. The primary outcome was in-hospital mortality. Secondary outcomes included ICU length of stay, hypoglycemia, severe hypoglycemia, mechanical ventilation duration, and nosocomial infection. Outcomes were analyzed using regression models appropriate to outcome type, with adjustment for prespecified covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After propensity score matching, 296 patients were included in the CGM group and 296 in the control group. Compared with standard point-of-care monitoring, CGM use was associated with lower in-hospital mortality (9.5% vs 15.5%; adjusted odds ratio [aOR] = 0.61, 95% CI 0.38\u20130.98; P\u00a0=\u00a00.027) and fewer severe hypoglycemic events (4.7% vs 10.8%; aOR = 0.46, 95% CI 0.25\u20130.85; P\u00a0=\u00a00.009). The CGM group also had a shorter median ICU length of stay (7 days [IQR 5\u201310] vs 9 days [IQR 6\u201313]; P\u00a0=\u00a00.021) and a lower incidence of nosocomial infection (12.2% vs 17.9%; aOR = 0.63, 95% CI 0.40\u20130.99; P\u00a0=\u00a00.048).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this retrospective propensity score\u2013matched cohort study, CGM-guided glucose management was associated with improved glycemic safety and more favorable in-hospital outcomes among critically ill adults who remained in the ICU for at least 72 hours. Because of the observational design, survivor-selection bias, residual confounding, and differences in measurement density, these findings should not be interpreted as evidence of causal benefit. Prospective multicenter studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1921773","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:29:03Z","timestamp":1788150543000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of continuous glucose monitoring with in-hospital adverse outcomes among critically ill patients: a real-world propensity score\u2013matched study"],"prefix":"10.3389","volume":"17","author":[{"given":"Zeyu","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Dong","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dandong Central Hospital of China Medical University","place":["Dandong, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.0508","article-title":"Diabetes mellitus and infectious diseases: Current evidence and clinical implications","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102566","article-title":"Longitudinal body mass index exposure-based threshold to prevent mortality for populations with type 2 diabetes mellitus","volume":"7","author":"Hu","year":"2026","journal-title":"Cell Rep Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13088","article-title":"Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-022-01484-x","article-title":"CGM in the hospital: Is it ready for prime time","volume":"22","author":"Buschur","year":"2022","journal-title":"Curr Diabetes Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.108106","article-title":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","volume":"36","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Its Complications"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-4642(20)30367-9","article-title":"Real-time continuous glucose monitoring in preterm infants (REACT): An international, open-label, randomised controlled trial","volume":"5","author":"Beardsall","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000004068","article-title":"Nursing activities score, nurse patient ratios, and ICU mortality: Its more complicated than that","volume":"48","author":"Scruth","year":"2020","journal-title":"Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13054-017-1784-0","article-title":"Continuous glucose monitoring in the ICU: Clinical considerations and consensus","volume":"21","author":"Krinsley","year":"2017","journal-title":"Crit Care (London England)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817698499","article-title":"Inpatient continuous glucose monitoring and glycemic outcomes","volume":"11","author":"Levitt","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07663-6","article-title":"Accuracy of continuous glucose monitoring systems in intensive care unit patients: A scoping review","volume":"50","author":"Nielsen","year":"2024","journal-title":"Intensive Care Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infection Control"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1352","article-title":"Real-time continuous glucose monitoring in critically ill patients: A prospective randomized trial","volume":"33","author":"Holzinger","year":"2010","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0453-9","article-title":"Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: A randomized controlled trial","volume":"18","author":"Boom","year":"2014","journal-title":"Crit Care (London England)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000006174","article-title":"Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024","volume":"52","author":"Honarmand","year":"2024","journal-title":"Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.06.021","article-title":"Continuous glucose monitoring (CGM) in a non-ICU hospital setting: The patient's journey","volume":"33","author":"Irace","year":"2023","journal-title":"Nutrition Metabolism Cardiovasc Dis NMCD"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2196\/67012","article-title":"Effectiveness of continuous glucose monitoring on short-term, in-hospital mortality among frail and critically ill patients with COVID-19: Randomized controlled trial","volume":"27","author":"Shang","year":"2025","journal-title":"J Med Internet Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06136-1","article-title":"Threshold of hyperglycaemia associated with mortality in critically ill patients: A multicentre, prospective, observational study using continuous glucose monitoring","volume":"67","author":"Wang","year":"2024","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211008446","article-title":"Use and accuracy of inpatient CGM during the COVID-19 pandemic: An observational study of general medicine and ICU patients","volume":"16","author":"Longo","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818821094","article-title":"Advancing the use of CGM devices in a non-ICU setting","volume":"13","author":"Wang","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211053652","article-title":"Use of continuous glucose monitoring in non-ICU hospital settings for people with diabetes: A scoping review of emerging benefits and issues","volume":"17","author":"Clubbs Coldron","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816648713","article-title":"Glucose control in the ICU: A continuing story","volume":"10","author":"Preiser","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06250-0","article-title":"Accuracy of continuous glucose monitoring in the hospital setting: An observational study","volume":"67","author":"O'Connor","year":"2024","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2021.201","article-title":"Continuous glucose monitoring in the hospital","volume":"36","author":"Perez-Guzman","year":"2021","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221076562","article-title":"Accuracy of continuous glucose monitors for inpatient diabetes management","volume":"17","author":"Wright","year":"2023","journal-title":"J Diabetes Sci Technol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1921773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:29:04Z","timestamp":1788150544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1921773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":26,"alternative-id":["10.3389\/fendo.2026.1921773"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1921773","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"1921773"}}